Academic literature on the topic 'Localized Drug Delivery System'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Localized Drug Delivery System.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Localized Drug Delivery System"
Malik, Mohit Saini Jitender K. "Novel Drug Delivery System Microsphere: A Review." SAR Journal of Anatomy and Physiology 3, no. 2 (April 29, 2022): 9–16. http://dx.doi.org/10.36346/sarjap.2022.v03i02.001.
Full textVigata, Margaux, Cathal D. O’Connell, Silvia Cometta, Dietmar W. Hutmacher, Christoph Meinert, and Nathalie Bock. "Gelatin Methacryloyl Hydrogels for the Localized Delivery of Cefazolin." Polymers 13, no. 22 (November 16, 2021): 3960. http://dx.doi.org/10.3390/polym13223960.
Full textSingh, Ranjit, and S. P. Vyas. "Topical liposomal system for localized and controlled drug delivery." Journal of Dermatological Science 13, no. 2 (November 1996): 107–11. http://dx.doi.org/10.1016/s0923-1811(96)00508-7.
Full textColon, Marlyn, Eva Christabel Williams, Ryan Toomey, and Norma Alcantar. "Localized Drug Delivery System For The Treatment Of Cancer." Biophysical Journal 96, no. 3 (February 2009): 687a. http://dx.doi.org/10.1016/j.bpj.2008.12.3629.
Full textMhambi, Sinaye, David Fisher, Moise B. Tchoula Tchokonte, and Admire Dube. "Permeation Challenges of Drugs for Treatment of Neurological Tuberculosis and HIV and the Application of Magneto-Electric Nanoparticle Drug Delivery Systems." Pharmaceutics 13, no. 9 (September 15, 2021): 1479. http://dx.doi.org/10.3390/pharmaceutics13091479.
Full textChristabel Williams, Eva, Ryan Toomey, and Norma Alcantar. "Double Packaged System for Localized Drug Delivery for Ovarian Cancer." Biophysical Journal 98, no. 3 (January 2010): 503a. http://dx.doi.org/10.1016/j.bpj.2009.12.2738.
Full textQuan, N., and C. M. Blatteis. "Microdialysis: A system for localized drug delivery into the brain." Brain Research Bulletin 22, no. 4 (April 1989): 621–25. http://dx.doi.org/10.1016/0361-9230(89)90080-4.
Full textGao, Weiwei, Yue Zhang, Qiangzhe Zhang, and Liangfang Zhang. "Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery." Annals of Biomedical Engineering 44, no. 6 (March 7, 2016): 2049–61. http://dx.doi.org/10.1007/s10439-016-1583-9.
Full textVigata, Margaux, Christoph Meinert, Stephen Pahoff, Nathalie Bock, and Dietmar W. Hutmacher. "Gelatin Methacryloyl Hydrogels Control the Localized Delivery of Albumin-Bound Paclitaxel." Polymers 12, no. 2 (February 24, 2020): 501. http://dx.doi.org/10.3390/polym12020501.
Full textIngale, Dipit Jagannath, N. H. Aloorkar, A. S. KulkarnI, and R. A. Patil Patil. "Microsponges as Innovative Drug Delivery Systems." International Journal of Pharmaceutical Sciences and Nanotechnology 5, no. 1 (May 31, 2012): 1597–606. http://dx.doi.org/10.37285/ijpsn.2012.5.1.2.
Full textDissertations / Theses on the topic "Localized Drug Delivery System"
Rodriguez, Lidia Betsabe. "Controlled Release System for Localized and Sustained Drug Delivery Applications." University of Toledo / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1365107103.
Full textFalahat, Rana. "Tunable Nano-Delivery System for Cancer Treatment: A New Approach for Targeted Localized Drug Delivery." Scholar Commons, 2016. http://scholarcommons.usf.edu/etd/6234.
Full textRodríguez, Escalona Gabriela de Jesús. "DEVELOPMENT OF CONTROLLED DRUG DELIVERY SYSTEMS OF POLYMERIC NANOMEDICINES ASSOCIATED TO SCAFFOLDS FOR TISSUE REGENERATION." Doctoral thesis, Universitat Politècnica de València, 2016. http://hdl.handle.net/10251/63231.
Full text[ES] Actualmente, una de las mayores preocupaciones que permanentemente laman la atención de los principales sectores de la sociedad humana es la salud. La ciencia médica moderna está comprometida no solo con suministrar tratamientos adecuados, sino más bien ofrecer soluciones efectivas y específicas para cada tipo de enfermedad o patología humana. En este sentido, estrategias innovadoras como la ingeniería de tejidos o la medicina regenerativa, los sistemas de liberación controlada de fármacos y las nanomedicinas, surgen como buenas alternativas para abordar situaciones difíciles de resolver aplicando los tratamientos y estrategias terapéuticas convencionales, como es el caso cuando se hace necesario reemplazar tejidos o incluso órganos dañados por algún traumatismo o enfermedad. Concretamente, el presente trabajo de investigación tiene por objetivo principal diseñar un sistema combinado para la liberación controlada, estable y localizada de agentes terapéuticos que sean capaces de ejercer su efecto de forma selectiva sobre la zona que amerita el tratamiento. Este constructo tendrá la versatilidad suficiente como para poder adaptarse a casi cualquier tipo de tratamiento, desde el cáncer hasta la regeneración de tejido, siempre que el requisito clave del tratamiento sea la necesidad de suministrar el tratamiento de manera localizada, estable y controlada. Para efectos de facilitar la compresión y el diseño del sistema se escogió para la prueba de concepto materiales y fármacos asociados a la regeneración de tejidos, como tratamiento para casos de heridas crónicas. El sistema en cuestión está constituido por tres elementos principales: 1) El primer elemento son los conjugados poliméricos de agentes terapéuticos que contribuirán a aumentar la selectividad de la acción terapéutica del fármaco, así como también a mejora la estabilidad, biodisponibilidad y biocompatibilidad de los mismos. En caso de que el fármaco sea hidrofóbico, la conjugación contribuye a aumentar su solubilidad en agua, y en el caso de usar proteínas como agentes terapéuticos, la conjugación contribuye a disminuir la respuesta inmunológica del cuerpo incrementando las posibilidad de éxito del tratamiento. 2) El segundo elemento son micropartículas poliméricas biodegradables, que en este caso actúan con agentes de encapsulación para los conjugados poliméricos, permitiendo así contar con un segundo punto de control en la cinética de liberación de los agentes terapéuticos. Simultáneamente, las micropartículas también cumplen un papel de modificador de la textura del constructo final, adjudicándole propiedades mecánica y fisicoquímicas que contribuyen a mejorar las propiedades biológicas del material final, como son la afinidad, la adhesión y la proliferación celular. 3) El tercer elemento consiste en una membrana polimérica biodegradable nanoporosa hecha por electrospinning, que constituyen el elemento unificados del sistema, aporta manejabilidad al constructo y es en sí mismo el último punto de control en la cinética de liberación del agente terapéutico. Este último debe ser biocompatible y estable en condiciones ambientales, puesto que probablemente este expuesto al ambiente mientras protege la herida, en el caso concreto de este tipo de aplicación. Estos tres elementos, que en sí mismos constituyen sistemas complejos por separado, se han combinado sistemáticamente para alcanzar una relación sinérgica entre ellos de manera que cada uno potencia las cualidades de los otros dos. El constructo resultante se caracterizó demostrando tener propiedades características que se pueden utilizar como parámetro de control durante la fabricación del mismo. Así mismo estudios in vitro del sistema desarrollado señalan que puede ser un buen candidato para el tratamiento de heridas crónicas entre otras patologías que requieran tratamientos localizados.
[CAT] Actualment, una de les majors preocupacions que permanentment llepen l'atenció dels principals sectors de la societat humana és la salut. La ciència mèdica moderna està compromesa no solament amb subministrar tractaments adequats, sinó més aviat oferir solucions efectives i específiques per a cada tipus de malaltia o patologia humana. En aquest sentit, estratègies innovadores com l'enginyeria de teixits o la medicina regenerativa, els sistemes d'alliberament controlat de fàrmacs i les nanomedicines, sorgeixen com a bones alternatives per a abordar situacions difícils de resoldre aplicant els tractaments i estratègies terapèutiques convencionals, com és el cas quan es fa necessari reemplaçar teixits o fins i tot òrgans danyats per algun traumatisme o malaltia. Concretament, el present treball de recerca té per objectiu principal dissenyar un sistema combinat per a l'alliberament controlat, estable i localitzada d'agents terapèutics que seguen capaços d'exercir el seu efecte de forma selectiva sobre la zona que amirita el tractament. Aquest constructe tindrà la versatilitat suficient com per a poder adaptar-se a quasi qualsevol tipus de tractament, des del càncer fins a la regeneració de teixit, sempre que el requisit clau del tractament sega la necessitat de subministrar el tractament de manera localitzada, estable i controlada. Per a efectes de facilitar la compressió i el disseny del sistema es va escollir per a la prova de concepte materials i fàrmacs associats a la regeneració de teixits, com a tractament per a casos de ferides cròniques. El sistema en qüestió està constituït per tres elements principals: 1) El primer element són els conjugats polimèrics d'agents terapèutics que contribuiran a augmentar la selectivitat de l'acció terapèutica del fàrmac, així com també a millora l'estabilitat, biodisponibilitat i biocompatibilitat dels mateixos. En cas que el fàrmac sega hidrofòbic, la conjugació contribueix a augmentar la seua solubilitat en aigua, i en el cas d'usar proteïnes com a agents terapèutics, la conjugació contribueix a disminuir la resposta immunològica del cos incrementant les possibilitat d'èxit del tractament. 2) El segon element són microparticles polimèriques biodegradables, que en aquest cas actuen amb agents d'encapsulació per als conjugats polimèrics, permetent així comptar amb un segon punt de control en la cinètica d'alliberament de l'agent terapèutics. Simultàniament, les microparticles també compleixen un paper de texturitzant del constructe final, adjudicant-li propietats mecànica i fisicoquímiques que contribueixen a millorar la propietats biològiques del material final, com són l'afinitat, l'adhesió i la proliferació cel·lular. 3) El tercer element consisteix en una membrana polimèrica biodegradable nanoporosa feta per electrospinning, que constitueixen el element unificats del sistema, aporta manejabilitat al constructe i és en si mateix el ultimi punt de control en la cinètica d'alliberament de l'agent terapèutic. Aquest últim ha de ser biocompatible i estable en condicions ambientals, ja que probablement aquest exposat a l'ambient mentre protegeix la ferida, en el cas concret d'aquest tipus d'aplicació. Aquests tres elements que en si mateixos constitueixen sistemes complexos per separat, s'han combinat sistemàticament per a aconseguir una relació sinergètica entre ells de manera que cadascun potencia les qualitats dels altres dos. El constructe resultant es va caracteritzar demostrant tenir propietats característiques que es poden utilitzar com a paràmetre de control durant la fabricació del mateix. Així mateix estudis in vitro del sistema desenvolupat assenyalen que pot ser un bon candidat per al tractament de ferides cròniques entre altres patologies que requeriren tractaments localitzats.
Rodríguez Escalona, GDJ. (2016). DEVELOPMENT OF CONTROLLED DRUG DELIVERY SYSTEMS OF POLYMERIC NANOMEDICINES ASSOCIATED TO SCAFFOLDS FOR TISSUE REGENERATION [Tesis doctoral no publicada]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/63231
TESIS
Daniel, Karen D. "An implantable device for localized drug delivery and sensing." Thesis, Massachusetts Institute of Technology, 2009. http://hdl.handle.net/1721.1/46608.
Full textIncludes bibliographical references (p. 117-120).
There are many potential clinical applications for localized drug delivery and sensing systems, such as cancer, vaccinations, pain management, and hormone therapy. Localized drug delivery systems reduce the amount of drug required for a therapeutic effect and the severity of side effects. Delivery of multiple chemicals has been demonstrated previously from a polymeric microreservoir device. This dime-sized device contains small reservoirs loaded with drug and separated from the outside environment by a degradable polymer membrane. This device was modified to allow minimally invasive implantation with a large-bore needle and has demonstrated in vitro pulsatile release of a model compound after a mock implantation step. A biodegradable sealing method was developed for the polymeric microreservoir device, which makes the device completely resorbable and eliminates the surgical removal step needed with a non-resorbable device. Localized sensing systems will allow early detection of diseases and provide a tool for developing personalized treatment programs. The polymer microchip platform has been combined with magnetic relaxation switch (MRSw) nanoparticle sensors to create an in vivo sensing device. MRSw are magnetic nanoparticles (iron oxide core, crosslinked dextran shell) that can detect a variety of analytes. MRSw are kept in the device by a molecular weight cut-off (MWCO) membrane which allows analytes free access to the nanoparticle sensors.
(cont.) The MRSw aggregate in the presence of the analyte they were designed to detect and this aggregation causes a decrease in the transverse relaxation time (T2), which can be detected with magnetic resonance imaging (MRI) or nuclear magnetic resonance relaxometry. In vitro sensing experiments were used to optimize the device design and characterize its performance. In vivo device-based sensing of hCG, a soluble biomarker that is elevated in testicular and ovarian cancer, has been demonstrated. Cell lines secreting hCG were used to produce ectopic tumors in nude mice. The sensing device was implanted and magnetic resonance imaging (MRI) quantified a T2 decrease in mice with tumors compared to control mice (no tumors). This device may be the first continuous monitoring device for cancer that can be implanted at the tumor site and demonstrates feasibility of MRSw measurements in vivo.
by Karen D. Daniel.
Ph.D.
Merritt, Sonia Raquel. "Improving surgical efficacy via localized anti-proliferative drug delivery." Case Western Reserve University School of Graduate Studies / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=case1402017214.
Full textMulamba, Peter. "Biomaterials Modeling Of Localized Hyperthermia And Drug Delivery For Breast Cancer." The Ohio State University, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=osu1229981884.
Full textMulamba, Peter. "Biomaterials modeling of localized hyperthermia and drug delivery for breast cancer." Columbus, Ohio : Ohio State University, 2009. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1229981884.
Full textWilliams, Eva Christabel. "Smart Packaging: A Novel Technique For Localized Drug Delivery For Ovarian Cancer." Scholar Commons, 2012. http://scholarcommons.usf.edu/etd/4257.
Full textLeach, Jeffrey Harold. "Magnetic Targeted Drug Delivery." Thesis, Virginia Tech, 2003. http://hdl.handle.net/10919/31261.
Full textMaster of Science
Nikam, Shantanu P. "LOCALIZED ANTIBIOTIC DELIVERY VIA VALINE BASED POLY(ESTER UREA)." University of Akron / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=akron1522931095020122.
Full textBooks on the topic "Localized Drug Delivery System"
Jain, Kewal K., ed. Drug Delivery System. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0363-4.
Full textDrug delivery system. New York: Humana Press, 2014.
Find full textShah, Nirmal, ed. Nanocarriers: Drug Delivery System. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-4497-6.
Full textJain, Kewal K., ed. Drug Delivery to the Central Nervous System. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-529-3.
Full textF, Smolen Victor, and Ball LuAnn, eds. Bioavailability control by drug delivery system design. New York: Wiley, 1985.
Find full textParfenyuk, E. V. Silica nanoparticles as drug delivery system for immunomodulator GMDP. New York, N.Y: ASME, 2012.
Find full textDavid, Ganderton, Jones T. M. 1942-, Pharmaceutical Society of Great Britain., and King's College (University of London). Chelsea Dept. of Pharmacy., eds. Drug delivery to the respiratory tract. Weinheim, Federal Republic of Germany: VCH, 1987.
Find full textGeest, Ronald van der. PK/PD based drug delivery system design: Iontophoretic apomorphine delivery in patients with Parkinson's disease. [Leiden: University of Leiden], 1998.
Find full textCheng, Erik Ho Yan. Combination of hydrogel and liposomes as a responsive drug delivery system. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.
Find full textSharma, Hari S., Dafin F. Muresanu, and Aruna Sharma, eds. Drug and Gene Delivery to the Central Nervous System for Neuroprotection. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-57696-1.
Full textBook chapters on the topic "Localized Drug Delivery System"
Marotta, James S. "Drug Delivery Systems for Localized Treatment of Disease." In Biomedical Devices and Their Applications, 33–60. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-662-06108-4_2.
Full textCampbell, Scott, and Niels Smeets. "Drug Delivery: Localized and Systemic Therapeutic Strategies with Polymer Systems." In Polymers and Polymeric Composites: A Reference Series, 1079–134. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-95987-0_32.
Full textCampbell, Scott, and Niels Smeets. "Drug Delivery: Localized and Systemic Therapeutic Strategies with Polymer Systems." In Polymers and Polymeric Composites: A Reference Series, 1–56. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92067-2_32-1.
Full textEppstein, Deborah A., Marjorie A. van der Pas, Brian B. Schryver, Philip L. Felgner, Carol A. Gloff, and Kenneth F. Soike. "Controlled-Release and Localized Targeting of Interferons." In Delivery Systems for Peptide Drugs, 277–83. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4757-9960-6_24.
Full textIbsen, Stuart, Michael Benchimol, Dmitri Simberg, and Sadik Esener. "Ultrasound Mediated Localized Drug Delivery." In Nano-Biotechnology for Biomedical and Diagnostic Research, 145–53. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-2555-3_14.
Full textWeaver, James C., Robert Langer, and Russell O. Potts. "Tissue Electroporation for Localized Drug Delivery." In Electromagnetic Fields, 301–16. Washington, DC: American Chemical Society, 1995. http://dx.doi.org/10.1021/ba-1995-0250.ch017.
Full textMakino, Kimiko. "Drug Delivery System." In Electrical Phenomena at Interfaces and Biointerfaces, 709–23. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2012. http://dx.doi.org/10.1002/9781118135440.ch40.
Full textGodin, Biana, Elka Touitou, Rajaram Krishnan, Michael J. Heller, Nicolas G. Green, Hossein Nili, David J. Bakewell, et al. "Drug Delivery System." In Encyclopedia of Nanotechnology, 587. Dordrecht: Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-90-481-9751-4_100192.
Full textYang, Qiuhong, and Laird Forrest. "Drug Delivery to the Lymphatic System." In Drug Delivery, 503–48. Hoboken, NJ: John Wiley & Sons, Inc, 2016. http://dx.doi.org/10.1002/9781118833322.ch21.
Full textOn, Ngoc H., Vinith Yathindranath, Zhizhi Sun, and Donald W. Miller. "Pathways for Drug Delivery to the Central Nervous System." In Drug Delivery, 353–82. Hoboken, NJ: John Wiley & Sons, Inc, 2016. http://dx.doi.org/10.1002/9781118833322.ch16.
Full textConference papers on the topic "Localized Drug Delivery System"
Wiranowska, Marzenna, Ryan Toomey, Rana Falahat, and Norma Alcantar. "Abstract 3615: Design for a flexible localized drug delivery system." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-3615.
Full textWiranowska, Marzenna, Ryan Toomey, Rana Falahat, and Norma Alcantar. "Abstract 3615: Design for a flexible localized drug delivery system." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-3615.
Full textBan, Jae-won, Kyo-in Koo, Sunkil Park, Gilsub Kim, and Dong-il Dan Cho. "Micro-Injection System for Localized Drug Delivery Using Embedded Solid Chemical Propellant." In 2007 Frontiers in the Convergence of Bioscience and Information Technologies. IEEE, 2007. http://dx.doi.org/10.1109/fbit.2007.110.
Full textWilliams, Eva Christabel, Marzenna Wiranowska, Ryan Toomey, and Norma Alcantar. "Abstract 3229: Thermo-responsive double packaged system for localized drug delivery for cancer treatment." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3229.
Full textKeyes, Joseph T., Bruce R. Simon, and Jonathan P. Vande Geest. "Transport in Pulsatile Axisymmetric Stented Arterial Models From Location-Dependent Variations in Permeability and Mechanical Properties." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53998.
Full textRidgeway, Shane, Junho Song, and Li Cao. "A Selectively Anodic Bonded Micropump for Implantable Medical Drug Delivery Systems." In ASME 2002 International Mechanical Engineering Congress and Exposition. ASMEDC, 2002. http://dx.doi.org/10.1115/imece2002-33551.
Full textMa, Bin, Sheng Liu, Zhiyin Gan, Guojun Liu, Xincia Cai, Honghai Zhang, and Zhigang Yang. "A PZT Insulin Pump Integrated With Silicon Needle Array for Transdermal Delivery." In ASME 4th International Conference on Nanochannels, Microchannels, and Minichannels. ASMEDC, 2006. http://dx.doi.org/10.1115/icnmm2006-96005.
Full textWilliams, Eva C., Ryan Toomey, Marcia Gordon, Donald Williams, Dave Morgan, and Norma Alcantar. "Abstract 3707: Design and characterization of a double packaged system for localized drug delivery for the treatment of cancers." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3707.
Full textKeyes, Joseph T., Leonardo G. Montilla, Russel S. Witte, and Jonathan P. Vande Geest. "Retention and Transport of Hydrophobic and Hydrophilic Drug Surrogate Molecules in Coronary Arteries Measured Nondestructively With Photoacoustic Ultrasound." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14626.
Full textStarly, Binil, Shih-Feng Lan, and David Schmidtke. "Customized Release of Metronidazole From Composite Casted Rings of Poly-Caprolactone/Alginate for Periodontal Drug Delivery." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14177.
Full textReports on the topic "Localized Drug Delivery System"
McPhillips, D. M., M. W. Price, J. W. Gibson, and R. A. Casper. Development of an On-Demand, Generic, Drug-Delivery System. Fort Belvoir, VA: Defense Technical Information Center, August 1985. http://dx.doi.org/10.21236/ada158550.
Full textPflugfelder Ghanashyam S., Stephen C. Broadly Applicable Nanowafer Drug Delivery System for Treating Eye Injuries. Fort Belvoir, VA: Defense Technical Information Center, September 2014. http://dx.doi.org/10.21236/ada613401.
Full textDash, Alekha K. Novel in Situ Gel Drug Delivery System for Breast Cancer Treatment. Fort Belvoir, VA: Defense Technical Information Center, July 2007. http://dx.doi.org/10.21236/ada474685.
Full textDeluca, Patrick P. Development of a Sustained Antiplague, Antimicrobial Delivery System for KSL Localized in the Oral Cavity. Fort Belvoir, VA: Defense Technical Information Center, May 2004. http://dx.doi.org/10.21236/ada428511.
Full textSledge, George W. Nanoparticle: Monoclonal Antibody Conjugates: A Novel Drug Delivery System in Human Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, May 2002. http://dx.doi.org/10.21236/ada420569.
Full textSledge, George. Nanoparticle: Monoclonal Antibody Conjugates: A Novel Drug Delivery System in Human Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, May 2000. http://dx.doi.org/10.21236/ada393348.
Full textBasu, Sayani. Nanoparticle-Based Therapeutics for the Treatment of Stroke. Nature Library Ltd, November 2020. http://dx.doi.org/10.47496/nl.blog.13.
Full textMunhuweyi, Ngonidzashe Portia, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. Resource Modelling for the QC Laboratory at XYZ Pharmaceuticals in Southern Africa. Purdue University, November 2021. http://dx.doi.org/10.5703/1288284317431.
Full textPerceptions of community pharmacists, patent and proprietary medicine vendors, and their clients regarding quality of family planning services: The IntegratE Project. Population Council, 2021. http://dx.doi.org/10.31899/rh17.1016.
Full textIntegratE Project results: Family planning knowledge and quality of care received from community pharmacists and patent and proprietary medicine vendors. Population Council, 2021. http://dx.doi.org/10.31899/sbsr2021.1018.
Full text